tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Stephan, 9 are a HOLD (34.62%), 17 are a BUY (65.38%).
Analyst Thomas Stephan, currently employed at STIFEL, carries an average stock price target met ratio of 66.52% that have a potential upside of 15.17% achieved within 66 days.
Thomas Stephan’s has documented 52 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RXST, Rxsight at 20-Dec-2024.
Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 12/8/2022. The price target of $60 was fulfilled within 1 day with a profit of $2.6 (4.15%) receiving and performance score of 41.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$162
$11.12 (7.37%)
$132
10 days ago
(11-Dec-2024)
18/19 (94.74%)
$16.84 (11.60%)
92
Buy
$153
$2.12 (1.41%)
$145
19 days ago
(02-Dec-2024)
6/7 (85.71%)
$12.35 (8.78%)
107
Buy
$149
$-1.88 (-1.25%)
$139
25 days ago
(26-Nov-2024)
7/7 (100%)
$8.91 (6.36%)
94
Buy
$145
$-5.88 (-3.90%)
$110
1 months 16 days ago
(05-Nov-2024)
8/8 (100%)
$15.91 (12.32%)
41
Buy
$137
$-13.88 (-9.20%)
$113
4 months 20 days ago
(01-Aug-2024)
12/12 (100%)
$19.39 (16.49%)
110
Which stock is Thomas Stephan is most bullish on?
Which stock is Thomas Stephan is most reserved on?
What Year was the first public recommendation made by Thomas Stephan?
